Tânia Silva Selected Research

Tânia Silva Research Topics

8	Infections 12/2021 - 01/2013
2	Anemia 11/2017 - 01/2017
1	Hashimoto's encephalitis 03/2022
1	Peritonitis 01/2022
1	Granuloma 12/2021
1	Disease Progression 12/2021
1	COVID-19 12/2021
1	Urinary Tract Infections (Urinary Tract Infection) 02/2021
1	Iron Overload 11/2017
1	Communicable Diseases (Infectious Diseases) 08/2017
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Visceral Leishmaniasis (Kala Azar) 12/2015
1	Schizophrenia (Dementia Praecox) 01/2014

5	IronIBA 12/2021 - 01/2013
3	Pharmaceutical PreparationsIBA 11/2017 - 09/2015
2	CytokinesIBA 12/2021 - 01/2017
2	ApoferritinsIBA 12/2021 - 01/2013
2	metal transporting protein 1 (ferroportin)IBA 12/2021 - 11/2017
2	HepcidinsIBA 11/2017 - 01/2017
1	AntibodiesIBA 03/2022
1	SteroidsIBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	tazobactam drug combination ceftolozaneIBA 02/2021
1	N 30IBA 02/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2017
1	Peptides (Polypeptides)IBA 07/2017
1	lactoferricin BIBA 07/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2017
1	Toll-Like Receptor 4IBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2015
1	Hepatitis C AntibodiesIBA 09/2015
1	benzoylamido- 4'- aminostilbene- 2,2'- disulfonate (BADS)IBA 01/2014
1	Toll-Like Receptor 2IBA 01/2013
1	Ferritins (Ferritin)IBA 01/2013

1	Therapeutics 03/2022
1	Peritoneal Dialysis 01/2022